Physician profile
Brett David Larson
NPI 1104142678
$459.35
in general payments reported to CMS, 2019-2025
11 companies · $78.10 in 2025
The $78.10 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.01 · 2021: $21.98 · 2022: $14.51 · 2023: $72.92 · 2024: $248 · 2025: $78.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276 · Education: $90.95 · Long Term Medical Supply Or Device Loan: $32.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $275.82 |
| Education | $90.95 |
| Long Term Medical Supply Or Device Loan | $32.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $157.55 | 2023-2024 | Veozah |
| Biogen, INC. | $63.20 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $49.77 | 2021-2023 | |
| Baxter Healthcare | $32.08 | 2024 | Hillrom - Spot Vision Screener |
| Coopersurgical, INC. | $31.69 | 2024-2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $25.51 | 2025 | Myfembree |
| Allergan, INC. | $24.01 | 2019 | |
| Organon LLC | $23.92 | 2023-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $18.39 | 2025 | Novasure |
| Evofem Biosciences, INC. | $16.83 | 2023 | Phexxi |
| Becton, Dickinson and Company | $16.40 | 2024 | Bd Onclarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.